On July 28, 2022, the National Academies of Sciences, Engineering, and Medicine (NASEM) published a report titled “Guidance on PFAS Exposure, Testing, and Clinical Follow-up.” This consensus study report was funded by the US Center for Disease Control and Prevention (CDC), the National Institutes of Environmental Health Sciences (NIEHS), the National Institutes of Health (NIH), and the Department of Health and Human Services (HHS).

The NASEM Report

The National Academies of Sciences, Engineering, and Medicine provide independent, objective analysis and advice to the nation in relation to complex problems and inform public policy decisions. The 278-page technical report is intended to assist those who live, work, and play where PFAS contamination exists in order to help them protect themselves from the risks of PFAS exposure.

Many people across the nation have been exposed to PFAS contamination in their drinking water and in the soil around their homes for decades with no knowledge of the risks.
The National Academies of Sciences, Engineering, and Medicine set out to create guidance for these people to provide explicit directions on when to test for PFAS, how to order tests, how to interpret the results, and what clinical follow-up should be performed for varying levels of PFAS exposure.

This NASEM report is very detailed and worth the read if you enjoy technical subject matter. However, we would like to highlight the findings of one portion of the report, namely Who should have their blood tested and what do the results mean for clinical care.

PFAS Associated Conditions/Risks

The NASEM Committee after conducting an extensive literature review found sufficient evidence of an association between PFAS exposure and the following conditions:
The NASEM Committee also found suggestive evidence of an association between PFAS exposure and the following conditions:

PFAS Screening Guidelines

If you have any of these conditions or have ever lived, worked, or recreated in an area with known PFAS contamination, biomonitoring may provide important information about PFAS exposure levels and provide guidance for following up with doctors on treatment. PFAS levels in blood is important information, but cannot be used to predict the likelihood of any of the above conditions occurring.

Anyone who has a likely history of significant PFAS exposure should be offered PFAS testing, including:

PFAS Exposure – Clinical Follow-up

For those that do have their blood tested, the NASEM Committee recommends that their physician use PFAS levels to inform clinical care with the following guidelines:

NASEM recommends persons with a PFAS concentration between 2 and 20 ng/mL, PFAS exposure reduction is encouraged. Persons in this category should also prioritize screening for dyslipidemia every 4-6 years. Pregnant women in this category should screen for hypertensive disorders at all prenatal visits. All women in this category should also be vigilant about screening for breast cancer based on age and risk factors as recommended by your physician.

NASEM recommends persons with higher than 20 ng/mL of PFAS concentration in their blood should immediately take actions to reduce their PFAS exposure. These persons also need to screen for dyslipidemia immediately and then at all well visits should, test thyroid function, screen for kidney cancer with urinalysis, and assess for signs of testicular cancer and ulcerative colitis.

The NASEM Study is an important step in providing standards for identification and treatment of PFAS related negative health outcomes.  As more information about treatment of PFAS related illness is documented, the NASEM will update this publication.

OUR team

We prefer doing to talking (except in court), We take the bull by the horns and give you clear and practical advice. Personal, to the point, and in plain language. Any questions? Feel free to call or to drop by.

After reviewing your medical costs, lost wages, and pain and suffering damages, we can help you understand what your case is worth and plan a road map going forward.
After reviewing your medical costs, lost wages, and pain and suffering damages, we can help you understand what your case is worth and plan a road map going forward.

$1.056 billion verdict against Exxon Mobil

If you think you may have a claim and need legal help to hold those parties responsible for damage that they have caused, contact an attorney from our firm.

Stag Liuzza fights industry giants across the country and holds them accountable for their actions. We strive to ensure that communities have access to safe drinking water, clean air, and a healthy environment.

stagliuzza.com is operated and provided by Stag Liuzza, LLC responsible attorneys Michael G. Stag and Ashley M. Liuzza. Stag Liuzza, LLC is officed in New Orleans, LA, and our attorneys are licensed in Louisiana and Mississippi.

Nothing on this site should be taken to establish an attorney-client relationship with us unless and until a contract for representation is signed. The attorneys of Stag Liuzza are licensed in Louisiana and Mississippi and may associate counsel licensed in other jurisdictions as necessary.

Past results do not guarantee any similar result or outcome in your claim. Each claim is different.

This website uses cookies to ensure you get the best experience on our website.